How peripherally administrated IFN-α (e.g., intravenous and intramuscular injection) induces depression has been well studied in animal models including rodents (Hoyo-Becerra et al., 2015) and non-human primates (Felger et al., 2007). Here, IFNA1 is linked to major depressive disorder.